Skip to content
High Tech Series B Founded 2001

SciTech Development

Developer of drug delivery platform for cancer therapeutics and clinical trials. The company focuses on improving bioavailability of water-insoluble therapeutics while maintaining safety. Their lead drug candidate combines the delivery platform with fenretinide. The company seeks funding and partnerships to assess safety and efficacy. The company was founded in 2001 and headquartered in United States. It has raised…

📍 United States · Nanotechnology,

Funding snapshot

Last roundSeries B
Amount$240K
Date1 October 2024
Total raised$6M
Team size12

About

Developer of drug delivery platform for cancer therapeutics and clinical trials. The company focuses on improving bioavailability of water-insoluble therapeutics while maintaining safety. Their lead drug candidate combines the delivery platform with fenretinide. The company seeks funding and partnerships to assess safety and efficacy. The company was founded in 2001 and headquartered in United States. It has raised $6M in series b funding, with backing from Pointe Angels, Storm Lake Capital, Harlem River Navy, Nfcr, and others. The company operates in the High Tech - Nanotechnology, Life Sciences - Oncology, Life Sciences - Drug Delivery space. Its offerings span Oncology - Drugs - Diversified and Drug Delivery - Nanoparticle Based.

Business model

Nanotechnology > Nanoenabled Products > Life Science > Drugs > Cancer,

Oncology > Drugs > Diversified,

Drug Delivery > Nanoparticle Based

Institutional investors

Pointe Angels Storm Lake Capital Harlem River Navy Nfcr Hud Exchange AIM-HI Accelerator Fund City Side Ventures

Latest coverage

No articles yet.

Raising like SciTech Development?

Analyze your pitch deck before your next raise.

Analyze My Deck →